Premium
Ligand selectivity of cloned human and rat opioid mu receptors
Author(s) -
Rothman Richard B.,
Xu Heng,
Wang Jia Bei,
Partilla John S.,
Kayakiri Hiroshi,
Rice Kenner C.,
Uhl George R.
Publication year - 1995
Publication title -
synapse
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.809
H-Index - 106
eISSN - 1098-2396
pISSN - 0887-4476
DOI - 10.1002/syn.890210109
Subject(s) - receptor , opioid , ligand (biochemistry) , chemistry , selectivity , functional selectivity , pharmacology , opioid receptor , neuroscience , microbiology and biotechnology , biochemistry , biology , g protein coupled receptor , catalysis
Opiate receptors play major roles in analgesic and euphoric effects of opiate drugs. Recent cloning of cDNAs encoding the rodent and human μ receptor revealed high homology between the predicted receptors but also some sequence differ‐ ences. To determine if these sequence differences produced significant changes in ligand‐selectivity profiles, we assessed these profiles in expressing COS and CHO cell lines using the agonist ligand [ 125 I]IOXY‐AG0 (6β‐[ 125 Iodo]‐3,14‐dihydroxy‐17‐methyl‐4,5α‐epoxymorphinan). This ligand's high specific activity (2, 200 Ci/mmol) and high affinity for μ opioid receptors generated high signal‐to‐noise ratio binding. The resulting ligand‐ selectivity profiles of the human and rat mu; receptors reveal modest differences in affinities for morphine and naloxone in COS cells but not CHO cells. Ligand‐selectivity profiles of the rat and human mu; receptors were otherwise similar. Interesting differences between these data and data previously obtained with the peptide agonist [ 3 H]DAMGO suggest that the peptide and alkaloid agonists may label different domains of the μ receptor. © 1995 Wiley‐Liss, Inc. 1 This article is a US Government work and as such, is in the public domain in the United States of America.